KANTARO
Live / Registered — Registered (as of 22 Mar 2022)
What this means for you
Registered since 22 Mar 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88922047
- Registration number
- 6680233
- Mark type
- Stylized text
- Filed
- 18 May 2020
- Published for opposition
- 27 Jul 2021
- Registered
- 22 Mar 2022
- Attorney of record
- Michelle A. Cooke
Goods and services
- Class 042 — Scientific and technological services: Medical, pharmaceutical, scientific and clinical research and analysis; Medical and scientific research in the fields of viral and infectious diseases; Design and development of medical diagnostic test kits; Research, analysis, design and development services relating to apparatus, instruments, devices and equipment for medical diagnostics and testing, medical diagnostic tests, and technical consultancy services relating to the foregoing; Providing medical testing services and information in the field of medical and viral and infectious diseases research; Development of scientific research and technology for purposes of disease testing, diagnosis, testing, monitoring, prevention, treatment and health maintenance; Conducting clinical trials for others relating to medical and pharmaceutical products; Research and development of pharmaceuticals for the treatment of infections, viruses, and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological and autoimmune diseases and disorders; Providing a website featuring medical research information, pharmaceutical research information, scientific research information and clinical research information about medical devices, diagnostics, research, analysis, monitoring and treatment of infections, viruses and infectious, viral, communicable, blood borne pathogen, vector borne, pulmonary, respiratory, inflammatory, immunological, autoimmune, rheumatic and cardiovascular diseases and disorders; Medical, scientific and clinical research regarding development of vaccines and medicines
Owner
- Kantaro Biosciences LLC, New York, NY, US
- Kantaro Biosciences LLC, New York, NY, US
- Kantaro Biosciences LLC, New York, NY, US
Prosecution history
- 22 Mar 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Feb 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 11 Feb 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 13 Jan 2022 — USE AMENDMENT FILED
- 28 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 13 Jan 2022 — TEAS STATEMENT OF USE RECEIVED
- 21 Sept 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 27 Jul 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Jul 2021 — PUBLISHED FOR OPPOSITION
- 07 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 21 Jun 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 18 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 17 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 17 Jun 2021 — TEAS RESPONSE TO OFFICE ACTION RECEIVED